NDC 50268-616

OLANZAPINE

Olanzapine

OLANZAPINE is a Oral Tablet, Orally Disintegrating in the Human Prescription Drug category. It is labeled and distributed by Avpak. The primary component is Olanzapine.

Product ID50268-616_83d42e44-b2e0-6e59-e053-2a91aa0a8f7e
NDC50268-616
Product TypeHuman Prescription Drug
Proprietary NameOLANZAPINE
Generic NameOlanzapine
Dosage FormTablet, Orally Disintegrating
Route of AdministrationORAL
Marketing Start Date2014-04-23
Marketing CategoryANDA / ANDA
Application NumberANDA091415
Labeler NameAvPAK
Substance NameOLANZAPINE
Active Ingredient Strength10 mg/1
Pharm ClassesAtypical Antipsychotic [EPC]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 50268-616-13

30 BLISTER PACK in 1 BOX (50268-616-13) > 1 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (50268-616-11)
Marketing Start Date2014-04-23
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 50268-616-11 [50268061611]

OLANZAPINE TABLET, ORALLY DISINTEGRATING
Marketing CategoryANDA
Application NumberANDA091415
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2014-10-23

NDC 50268-616-13 [50268061613]

OLANZAPINE TABLET, ORALLY DISINTEGRATING
Marketing CategoryANDA
Application NumberANDA091415
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2014-04-23

Drug Details

Active Ingredients

IngredientStrength
OLANZAPINE10 mg/1

OpenFDA Data

SPL SET ID:98697cfd-5521-f8a9-af17-555031690b08
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 351107
  • 314155
  • 312076
  • Pharmacological Class

    • Atypical Antipsychotic [EPC]
    • Atypical Antipsychotic [EPC]

    Medicade Reported Pricing

    50268061613 OLANZAPINE ODT 10 MG TABLET

    Pricing Unit: EA | Drug Type:

    50268061611 OLANZAPINE ODT 10 MG TABLET

    Pricing Unit: EA | Drug Type:

    NDC Crossover Matching brand name "OLANZAPINE" or generic name "Olanzapine"

    NDCBrand NameGeneric Name
    67877-175OlanzapineOlanzapine
    67877-174OlanzapineOlanzapine
    67877-172OlanzapineOlanzapine
    67877-173OlanzapineOlanzapine
    67877-176OlanzapineOlanzapine
    67877-177OlanzapineOlanzapine
    68084-529OlanzapineOlanzapine
    68084-723OlanzapineOlanzapine
    68084-528OlanzapineOlanzapine
    68084-740OlanzapineOlanzapine
    68084-525OlanzapineOlanzapine
    68258-7095OlanzapineOlanzapine
    68258-7152OlanzapineOlanzapine
    68258-7153OlanzapineOlanzapine
    68258-7154OlanzapineOlanzapine
    68382-365olanzapineolanzapine
    68382-368olanzapineolanzapine
    68258-7096OlanzapineOlanzapine
    68382-367olanzapineolanzapine
    68382-364olanzapineolanzapine
    68382-366olanzapineolanzapine
    68382-369olanzapineolanzapine
    68788-7161OlanzapineOlanzapine
    0517-0955OlanzapineOlanzapine
    69189-5510OlanzapineOlanzapine
    69543-384OlanzapineOlanzapine
    69543-380OlanzapineOlanzapine
    69543-381OlanzapineOlanzapine
    69543-383OlanzapineOlanzapine
    69543-382OlanzapineOlanzapine
    69543-385OlanzapineOlanzapine
    69807-2012OlanzapineOlanzapine
    69807-2011OlanzapineOlanzapine
    69807-2013OlanzapineOlanzapine
    70518-0026OlanzapineOlanzapine
    70518-0148OlanzapineOlanzapine
    70518-0145OlanzapineOlanzapine
    70518-0149OlanzapineOlanzapine
    70518-0314OlanzapineOlanzapine
    70518-0477OlanzapineOlanzapine
    70518-0110OlanzapineOlanzapine
    70518-0616OlanzapineOlanzapine
    70518-0144OlanzapineOlanzapine
    70518-0433OlanzapineOlanzapine
    70518-1206OlanzapineOlanzapine
    70518-0921OlanzapineOlanzapine
    70518-1207OlanzapineOlanzapine
    70518-0615OlanzapineOlanzapine
    70518-1115OlanzapineOlanzapine
    70518-1154OlanzapineOlanzapine

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.